Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Pearl-Yafe

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biochemical Pharmacology|March 24, 2004
The p38 pathway partially mediates caspase-3 activation induced by reactive oxygen species in Fanconi anemia C cellsMichal Pearl-Yafe, Drora Halperin, Oded Scheuerman, et al.
Autoimmunity Reviews|June 20, 2006
Does physiological beta cell turnover initiate autoimmune diabetes in the regional lymph nodes?Michal Pearl-Yafe, Svetlana Iskovich, Ayelet Kaminitz, et al.
Biochemical Pharmacology|March 12, 2003
An oxidative mechanism of interferon induced priming of the Fas pathway in Fanconi anemia cellsMichal Pearl-Yafe, Drora Halperin, Ayelet Halevy, et al.
Shock (Augusta, Ga.)|February 17, 2007
Interferon-gamma and bacterial lipopolysaccharide act synergistically on human neutrophils enhancing interleukin-8, interleukin-1beta, tumor necrosis factor-alpha, and interleukin-12 p70 secretion and phagocytosis via upregulation of toll-like receptor 4Michal Pearl-Yafe, Ina Fabian, Drora Halperin, et al.
Current Pharmaceutical Design|March 10, 2007
Pancreatic islets under attack: cellular and molecular effectorsMichal Pearl-Yafe, Ayelet Kaminitz, Esma S Yolcu, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 26, 2006
The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantationMichal Pearl-Yafe, Esma S Yolcu, Isaac Yaniv, et al.
Current Stem Cell Research & Therapy|January 29, 2008
Participation of adult bone marrow-derived stem cells in pancreatic regeneration: neogenesis versus endogenesisSvetlana Iskovich, Ayelet Kaminitz, Michal Pearl Yafe, et al.
Experimental Hematology|September 25, 2007
Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosisMichal Pearl-Yafe, Esma S Yolcu, Jerry Stein, et al.
Stem Cells (Dayton, Ohio)|March 17, 2007
Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactionsMichal Pearl-Yafe, Esma S Yolcu, Jerry Stein, et al.
Stem Cells (Dayton, Ohio)|September 18, 2007
Fas transduces dual apoptotic and trophic signals in hematopoietic progenitorsMichal Pearl-Yafe, Jerry Stein, Esma S Yolcu, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biochemical Pharmacology|March 24, 2004
The p38 pathway partially mediates caspase-3 activation induced by reactive oxygen species in Fanconi anemia C cellsMichal Pearl-Yafe, Drora Halperin, Oded Scheuerman, et al.
Autoimmunity Reviews|June 20, 2006
Does physiological beta cell turnover initiate autoimmune diabetes in the regional lymph nodes?Michal Pearl-Yafe, Svetlana Iskovich, Ayelet Kaminitz, et al.
Biochemical Pharmacology|March 12, 2003
An oxidative mechanism of interferon induced priming of the Fas pathway in Fanconi anemia cellsMichal Pearl-Yafe, Drora Halperin, Ayelet Halevy, et al.
Shock (Augusta, Ga.)|February 17, 2007
Interferon-gamma and bacterial lipopolysaccharide act synergistically on human neutrophils enhancing interleukin-8, interleukin-1beta, tumor necrosis factor-alpha, and interleukin-12 p70 secretion and phagocytosis via upregulation of toll-like receptor 4Michal Pearl-Yafe, Ina Fabian, Drora Halperin, et al.
Current Pharmaceutical Design|March 10, 2007
Pancreatic islets under attack: cellular and molecular effectorsMichal Pearl-Yafe, Ayelet Kaminitz, Esma S Yolcu, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 26, 2006
The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantationMichal Pearl-Yafe, Esma S Yolcu, Isaac Yaniv, et al.
Current Stem Cell Research & Therapy|January 29, 2008
Participation of adult bone marrow-derived stem cells in pancreatic regeneration: neogenesis versus endogenesisSvetlana Iskovich, Ayelet Kaminitz, Michal Pearl Yafe, et al.
Experimental Hematology|September 25, 2007
Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosisMichal Pearl-Yafe, Esma S Yolcu, Jerry Stein, et al.
Stem Cells (Dayton, Ohio)|March 17, 2007
Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactionsMichal Pearl-Yafe, Esma S Yolcu, Jerry Stein, et al.
Stem Cells (Dayton, Ohio)|September 18, 2007
Fas transduces dual apoptotic and trophic signals in hematopoietic progenitorsMichal Pearl-Yafe, Jerry Stein, Esma S Yolcu, et al.
Pageof 2